Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Absolutely they do need money. But they don’t need it tomorrow. They should be good for at least 6 months, which takes them through ASCO. If this can drift up like most do under the ASCO effect and then release some data which is already slotted for 1H, then maybe this gets up close to 10 or so. Do an offering on that momentum and cover your expenses for another 6-12 months without massively diluting existing SH. Heck if DO was able to bring in $200M at an average cost of $12, then surely ADXS can find someone to do just as good a job as him right? I mean the company is stronger now than it was, they have millions of RSU to give away, DO has since been fired/left, Bio is heating up, M&A is heating up, plenty of new investors out there that have not been previously burned by ADXS or DO, so surely they can find a solid reputable CEO out there somewhere to run this company for the next 2-3 years. It doesn’t matter what the SP does day to day. As long as the science is solid in the end and they can keep enough money in the bank to keep the lights on (and fund everyone’s paycheck) then it is just a waiting game for everyone.